Effects of the dual orexin receptor antagonist DORA‐22 on sleep in 5XFAD mice

Abstract Introduction Sleep disruption is a characteristic of Alzheimer's disease (AD) that may exacerbate disease progression. This study tested whether a dual orexin receptor antagonist (DORA) would enhance sleep and attenuate neuropathology, neuroinflammation, and cognitive deficits in an AD...

Full description

Bibliographic Details
Published in:Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Main Authors: Marilyn J. Duncan, Hannah Farlow, Chairtra Tirumalaraju, Do‐Hyun Yun, Chanung Wang, James A. Howard, Madison N. Sanden, Bruce F. O'Hara, Kristen J. McQuerry, Adam D. Bachstetter
Format: Article
Language:English
Published: Wiley 2019-01-01
Subjects:
Online Access:https://doi.org/10.1016/j.trci.2019.01.003